Co-Authors
This is a "connection" page, showing publications co-authored by Weijin Huang and Jiajing Wu.
Connection Strength
1.944
-
The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. Front Immunol. 2021; 12:687869.
Score: 0.951
-
Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants. Cell Discov. 2021 Jul 20; 7(1):53.
Score: 0.239
-
Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system. Vaccine. 2017 11 07; 35(47):6387-6394.
Score: 0.184
-
Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants. Emerg Microbes Infect. 2021 Dec; 10(1):1519-1529.
Score: 0.061
-
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cell Res. 2021 07; 31(7):732-741.
Score: 0.059
-
Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants. Signal Transduct Target Ther. 2021 05 17; 6(1):196.
Score: 0.059
-
Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses. Cell Discov. 2021 Apr 06; 7(1):21.
Score: 0.059
-
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021 04 29; 184(9):2362-2371.e9.
Score: 0.058
-
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020 Dec; 9(1):680-686.
Score: 0.057
-
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals. Nat Microbiol. 2021 01; 6(1):51-58.
Score: 0.057
-
Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020 11; 15(11):3699-3715.
Score: 0.057
-
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020 09 03; 182(5):1284-1294.e9.
Score: 0.056
-
An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions. Vaccine. 2017 09 12; 35(38):5172-5178.
Score: 0.045